Top Section/Ad
Top Section/Ad
Most recent
Two big infrastructure deals with private capital providers are fuelling hopes of a sustained M&A rebound in Germany
SMG’s drop below offer price sends mixed signals
SMG pares back gains after year’s largest IPO, Verisure to follow
Italy’s top independent investment bank must try to survive inside Monte dei Paschi
More articles/Ad
More articles/Ad
More articles
-
China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing. -
Schroder British Opportunities Trust, a new listed fund set up by Schroders to invest in undervalued UK equities, has completed its IPO on the London Stock Exchange, raising just £75m.
-
JD Health International is set to close the international investor book for its up-to HK$27bn ($3.5bn) IPO a day early, according to a source familiar with matter.
-
Evergrande Property Services Group, the property management arm of one China’s most debt-laden developers, wrapped up its IPO toward the bottom of price guidance after relying largely on Chinese investors.
-
Chinese property developer Datang Group Holdings has set its IPO in motion, opening the book for an offer that could fetch up to HK$1.5bn ($197.9m).
-
Tech companies dominated the IPO market this year. But as the world starts to see an end to the coronavirus pandemic, signs are emerging that investors will be fed a far more balanced diet of companies looking to list, write Aidan Gregory and Sam Kerr.
